Efficacy and safety of new direct antiviral agents in hepatitis C virus-infected patients with diffuse large B-cell non-Hodgkin's lymphoma.

Marcello PersicoAndrea AglittiRosa CarusoAmalia De RenzoCarmine SelleriCatello CalifanoLudovico AbenavoliAlessandro FedericoMario Masarone

Published in: Hepatology (Baltimore, Md.) (2017)

DAA treatment in concomitance with chemotherapy was shown to be safe and effective in influencing remission of aggressive lymphomas in HCV patients. (Hepatology 2018;67:48-55).

Keyphrases

hepatitis c virus
end stage renal disease
human immunodeficiency virus
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
diffuse large b cell lymphoma
rheumatoid arthritis
radiation therapy
ulcerative colitis